drugset
drugset / Trial / NCT03169166

The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies

NCT03169166 ↗

Phase 4 Completed 277 enrolled American University of Beirut Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a prospective comparative randomized controlled trial investigating the effect of two GnRH agonist trigger protocols on the ongoing pregnancy rate in hyper-responder women undergoing assisted reproductive technology.

Timeline

Start
2017-03-01
Primary completion
2021-07-01
Completion
2021-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 0.2 mg Subcutaneous
Subject Triptorelin Other / unclassified 0.3 mg Subcutaneous

Indications

female infertility